Darshana Zaveri is a Managing Partner of Catalyst Health Ventures in Boston. She is actively involved in all aspects of Fund Management including Investments and Capital Raising. She led Catalyst’s investments in Augmenix, Lantos Technologies, nVision Medical, Maxwell Health, Aria CV and Hepregen. Darshana as over a decade of experience in the health care and Life Science Industries. She was an early investor in nVision, a FemTech company recently acquired by Boston Scientific for $275 million. Darshana is a Venture Partner in the Portfolia FemTech Fund™.
Juliana is currently the Director of the TMC Venture Fund at the Texas Medical Center. She formerly served as the Managing Director of The Houston Angel Network (HAN), which has invested $73M in 170 companies, making it the most active angel network in the world. Juliana is also a Kauffman Fellow in Class 20, a prestigious two-year, Silicon Valley-based leadership program for venture capitalists. Juliana is a Venture Partner in the Rising Tide Fund and the Portfolia Consumer Fund.
Barbara Clarke has become an emerging force on the Boston innovation scene. No less than Flybridge General Partner Jeff Bussgang recognized her as one of a handful of Boston-based Super Angels, having backed 30+ companies in the past five years. A noted economist and community activist, Barbara also co-founded The Impact Seat. Of note is Barbara’s deep investment portfolio that includes people of color, which she sees as one of the most attractive growth areas for venture investment. Barbara is a Venture Partner in three Portfolia Funds: The Rising Tide Fund, Portfolia Enterprise Fund, and Portfolia FirstStep Fund™.